Trichomonas Rapid Tests Market

Future Market Insights

Key Insight

The trichomonas rapid tests market is projected to grow from USD 485.2 million in 2025 to USD 793.0 million by 2035, at a CAGR of 5.0%. Cassette Rapid Test Kit will dominate with a 54.6% market share, while vaginal/urethra swab will lead the sample type segment with a 57.3% share.

September 26, 2025

Anurag Sharma

217 Pages

Cite this Report

Trichomonas Rapid Tests Market

https://www.futuremarketinsights.com/reports/trichomonas-rapid-tests-market

License

Buy Now

Summary ToC Companies

Key Players

Cardinal Health
FDA certifications
Home Health Ltd
Jei Daniel Biotech Corp
Norgen Biotek Corp
On 6th March 2025
On 8 September 2025
Orient Gene Biotech's Rapid COVID-19 Antigen Self-Test
Quidel Corporation

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Trichomonas Rapid Tests Market

Key Players

Similar Industry Reports